More Articles
Treatment for Non-Hodgkin’s Lymphomas (NHL) differs from patient to...
A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...
Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...
More Articles
With any cancer, early detection is the best predictor of long-term survival, and lymphoma is no
Diffuse large B cell lymphoma prognosis is contingent upon
The pathophysiology of lymphoma refers to the process or processes going on inside the body that
It's very common for people recently diagnosed with a subtype of
Canine lymphoma, just like lymphoma in
Mantle cell lymphoma (MCL) is just one of 50-60 known
Lymphoma is a general term for cancer in the lymph system. The lymph system is made up of many
There are four stages of both Non-Hodgkin's Lymphoma (NHL)
More Articles
Fourteen months ago I profiled Biovest and the company's innovative therapeutic follicular lymphoma vaccine, BiovaxID. To the amazement...
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...
Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...
Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...
The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...
A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...
Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...
Chemotherapy is the use of drugs to kill cancer cells and shrink tumors. Chemotherapy is...
Non-Hodgkin's lymphoma is a general term for a large group of lymphatic cancers that comprise approximately...
Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...
There are myriad lymphoma resources on the web. This list represents what we believe to be the most comprehensive and authoritative lymphoma sites...